MyFinsight
Home
About
Contact
smnr: the income statement
Download
Download image
Net loss and
comprehensive loss
-$152,594K
Loss from operations
-$152,594K
Total operating
expenses
$152,594K
General and
administrative
$151,451K
Research and development
$1,143K
Back
Back
Income Statement
source: myfinsight.com
Semnur Pharmaceuticals, Inc. (SMNR)
Semnur Pharmaceuticals, Inc. (SMNR)